Close
Open Nav
2019 Schedule of Events

Tuesday, October 22

6:30am - 5:00pm

Registration, California West Room 

6:30am - 5:30pm

Partnering Customer Service Desk, Sussex Room

7:00am - 7:55am

Networking Breakfast, California West Room

7:20am - 5:30pm

Satellite Partnering Desk, 3rd & 4th Floor

7:30am - 5:30pm

Partnering Meetings, 3rd & 4th Floors; Partnering Hospitality Suite, 3rd Floor

8:30am - 4:55pm 

Company Presentations, Elizabethan Rooms A-D & Yorkshire Room

8:30am - 9:40am 

The Next Wave of Cancer Treatments: Allogenic Cell Therapies and Other Pioneers

9:45am - 10:40am

Private Investors' Incubators for University-Sourced Ideas

10:45am - 11:40am

Gene Therapies: Pipelines Into A New Era for Patients

12:00pm - 1:25pm

Plenary Luncheon - Public Policy Outlook

2:00pm - 2:55pm

Fireside Chat: Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, BioMarin

3:00pm - 3:55pm

Recruiting Talent to Meet Corporate Board Requirements and Representation Goals

4:00pm - 4:55pm

View from the Board: Making an Acquisition Offer

5:30pm - 6:30pm

Opening Reception

 

Wednesday, October 23

6:30am - 5:00pm

Partnering Customer Service Desk, Sussex Room 

6:50am - 5:00pm

Satellite Partnering Desk, 3rd & 4th Floors

7:00am - 7:55am

Networking Breakfast, California West Room

7:00am - 4:30pm

Registration, California West Room; Partnering Hostpitality Suite, 3rd Floor

7:00am - 5:00pm

Partnering Meetings, 3rd & 4th Floors

8:30am - 4:55pm 

Company Presentations, Elizabethan Rooms A-D & Yorkshire Room

8:30am - 9:40am 

Progress in CNS Drug Development Outside Dementia

9:45am - 10:40am

Advice on Pitching to Family Offices, Venture Philanthropies, and Other Non-VC Funding Sources

10:45am - 11:40am

Molecular Diagnostics: Drivers of New Investor Interest and Reimbursement Success

12:00pm - 1:25pm

Fireside Chat: Wende Hutton, General Partner, Canaan

1:45pm - 2:40pm

Separating Artificial Intelligence Hype from Real Utility in Drug Development

2:45pm - 3:55pm

Best Practices in Biopharma Alliances with Digital Therapeutics Partners

4:00pm - 4:55pm

Market Outlook - Taking the Temperature of the IPO Market in an Era of Large Pharma M&A